1. Effects of Nintedanib in an Animal Model of Liver Fibrosis. (31st March 2020) Authors: Wollin, Lutz; Togbe, Dieudonnée; Ryffel, Bernhard Other Names: Dunne Nicholas Academic Editor. Journal: BioMed research international Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fibroblast–matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast‐conditioned matrix on normal fibroblast phenotype. Issue 8 (12th March 2018) Authors: Epstein Shochet, Gali; Wollin, Lutz; Shitrit, David Journal: Respirology Issue: Volume 23:Issue 8(2018) Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fibrosing interstitial lung diseases: knowns and unknowns. (27th February 2019) Authors: Cottin, Vincent; Wollin, Lutz; Fischer, Aryeh; Quaresma, Manuel; Stowasser, Susanne; Harari, Sergio Journal: European respiratory review Issue: Volume 28:Number 151(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Interpretation of data from studies of effects of nintedanib on surfactant protein-D expression in human lung epithelial cells. (August 2015) Authors: Wollin, Lutz Journal: Pulmonary pharmacology & therapeutics Issue: Volume 33(2015:Aug.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension. Issue 2 (18th July 2018) Authors: Rol, Nina; de Raaf, Michiel A; Sun, Xiaoqing Q; Kuiper, Vincent P; da Silva Gonçalves Bos, Denielli; Happé, Chris; Kurakula, Kondababu; Dickhoff, Chris; Thuillet, Raphael; Tu, Ly; Guignabert, Christophe; Schalij, Ingrid; Lodder, Kirsten; Pan, Xiaoke; Herrmann, Franziska E; van Nieuw Amerongen, Ge... Journal: Cardiovascular research Issue: Volume 115:Issue 2(2019) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis. Issue 5 (9th April 2015) Authors: Huang, Jingang; Beyer, Christian; Palumbo-Zerr, Katrin; Zhang, Yun; Ramming, Andreas; Distler, Alfiya; Gelse, Kolja; Distler, Oliver; Schett, Georg; Wollin, Lutz; Distler, Jörg H W Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 5(2016) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Issue 11 (16th August 2017) Authors: Huang, Jingang; Maier, Christiane; Zhang, Yun; Soare, Alina; Dees, Clara; Beyer, Christian; Harre, Ulrike; Chen, Chih-Wei; Distler, Oliver; Schett, Georg; Wollin, Lutz; Distler, Jörg H W Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 11(2017) Page Start: 1941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator. Issue 3 (September 2017) Authors: De Ruysscher, Dirk; Granton, Patrick Vincent; Lieuwes, Natasja Gaby; van Hoof, Stefan; Wollin, Lutz; Weynand, Birgit; Dingemans, Anne-Marie; Verhaegen, Frank; Dubois, Ludwig Journal: Radiotherapy and oncology Issue: Volume 124:Issue 3(2017:Sep.) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Olodaterol shows anti‐fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis. (20th September 2017) Authors: Herrmann, Franziska Elena; Wollin, Lutz; Wirth, Johannes; Gantner, Florian; Lämmle, Bärbel; Wex, Eva Journal: British journal of pharmacology Issue: Volume 174:Number 21(2017) Page Start: 3848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Issue 3 (19th September 2019) Authors: Wollin, Lutz; Distler, Jörg H.W.; Redente, Elizabeth F.; Riches, David W.H.; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Maher, Toby M.; Kolb, Martin Journal: European respiratory journal Issue: Volume 54:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗